(Q61921241)

English

High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis

clinical trial

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

Rare Disease With Microvascular Involvement: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis (English)

0 references

country

Italy

0 references

start time

January 2007

0 references

number of participants

45

0 references

research intervention

acetylcysteine

0 references

N-monoacetylcystine

0 references

(5E)-5-[(3aS,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]hexahydro-2(1H)-pentalenylidene]pentanoic acid

0 references

clinical trial phase

phase II clinical trial

0 references

phase III clinical trial

0 references

research subject recruitment status

unknown

0 references

minimum age

18 year

0 references

maximum age

80 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00428883

0 references

(Q61921241)

High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)